glp-1 for non diabetics The cardiovascular effects of receptor agonists beyond obesity and type 2 diabetes: An anti-atherosclerotic action The Antiobesity Potential of GLP-1

The researchers concluded that most of these hormonal changes (particularly TSH and free T3) appeared to be independent of weight loss, suggesting a possible direct effect of semaglutide on thyroid regulation that still needs to be clarified, while changes in free T4 were more closely related to weight change

Intermittent fasting is such a powerful tool in terms of lowering glycaemia that, in some patients, the dose of hypoglycaemic drugs needs to be adjusted (often significantly reduced)

Epub 2013 Nov 1

Spectrum of neurocognitive impairment in cirrhosis: implications for the assessment of hepatic encephalopathy